Aidapak Recalls Cholecalciferol Capsules Due to Potential Label Mixup
Aidapak Services, LLC is recalling 50,000-unit Cholecalciferol capsules because they may be mislabeled as Fenofibrate tablets. The repacked drugs were distributed in four western states.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling mixup. Per the rubric, minor labeling errors and voluntary precautionary recalls without reported injuries fall under the Moderate severity category.
Plain-English summary
Aidapak Services, LLC is recalling Cholecalciferol Capsules, 50,000 units, Over The Counter, NDC 53191036201. The recall is due to a labeling error where the product may be mislabeled as Fenofibrate, Tablet, 54 mg, NDC 00378710077. The affected product has the pedigree AD60268_4 and an expiration date of 5/22/2014.
The repacked drugs were distributed in Arizona, California, Oregon, and Washington. The source text does not specify the exact number of units recalled or the specific retail locations where the product was sold.
Consumers should check their medication for the specific NDC and pedigree listed above. If the product matches the description, they should stop using it and contact their pharmacist or the recalling firm for instructions on return or disposal.
The recalled product
- Product
- CHOLECALCIFEROL Capsule, 50000 units, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 53191036201
- Manufacturer
- Aidapak Services, LLC
- Hazard
- Affected units
- 100
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- CHOLECALCIFEROL
- Capsule
- 50000 units has the following code Pedigree: AD60268_4
- EXP: 5/22/2014.
Distribution
Part of a larger recall action
This product is one of 273 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 273 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateAidapak Recalls Cholecalciferol Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- SevereAidapak Recalls Cholecalciferol Capsules Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Fenofibrate Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Calcium Carbonate Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateFDA Recalls Fenofibrate Tablets Due to Potential Labeling Error
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Imipramine Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29